Usefulness of factor V Leiden mutation testing in clinical practice. Eur J Hum Genet. 2010; 18 :862–6. [ PMC free article ] [ PubMed ]Blinkenberg EO, Kristoffersen AH, Sandberg S, Steen VM, Houge G. Usefulness of factor V Leiden mutation testing in clinical practice. Eur J Hum Genet...
(redirected fromFactor V Leiden mutation) Thesaurus Medical Legal Acronyms Encyclopedia mu·ta·tion (myo͞o-tā′shən) n. 1.The act or process of being altered or changed. 2.An alteration or change, as in nature, form, or quality. ...
Theoretical considerations The factor V Leiden (FVL) mutation is the most prevalent inheritable risk factor for venous thromboembolism (VTE) 1. Heterozygous carriers of FVL have an approximately 3-to 5-fold increased risk of VTE, whereas the risk in homozygous carriers is estimated to be up to ...
Inappropriate Testing and Treatment of Factor V Leiden and Other Heritable ThrombophiliasScott J. Parsons DO aSven R. Olson MD bThomas G. DeLoughery MD, MACP, FAWM bThe American Journal of Medicine
Factor V Leiden and thrombosis in patients with inflammatory bowel disease (IBD): A meta-analysis Testing for genetic risks of Factor V Leiden ( FVL ) in inflammatory bowel disease (IBD) patients with thromboembolism (TE) is common, but the safety and u... Z Ming,WD Xian,Q Zheng,... ...
Medical genetic test reporting for cystic fibrosis (deltaF508) and factor V Leiden in North American laboratories. Genet Med 2002;4:324 -327.Andersson HC, Krousel-Wood MA, Jackson KE, Rice J, Lubin IM: Medical genetic test reporting for cystic fibrosis (deltaF508) and factor V Leiden in...
5) factor V coagulant activity 凝血因子V活性 1. Objective To develop a practical method of preparing coagulation factor V deficient plasma for testingfactor V coagulant activity(FV C) clinically in patients with viral hepatitis. 目的:探讨乏凝血因子V血浆制备方法及凝血因子V活性 (FV C)测定病毒性肝炎...
As dis- cussed in the ACMG Consensus Statement on Factor V Leiden Mutation Testing,1 factor V Leiden testing is predominantly used and recommended for diagnostic purposes in individuals with clinical symptoms of venous thrombosis or with recur- rent pregnancy loss. Although predictive testing in a...
A thrombophilia panel and genetic testing for Factor V Leiden (FVL), G20210A Prothrombin and MTHFR polimorphisms were done. Results: A total of 323 persons were enrolled: 71 women and 121 men with thromboembolic events, and 131 healthy female as controls. Hyperhomocysteinemia was more frequent...
Factor V Leiden testing is not routinely recommended during pregnancy or before the use of estrogen contraception, hormone replacement, or SERMs. Prenatal testing and screening of asymptomatic newborns, neonates, and children are also not recommended. Routine testing is not appropriate for patients ...